Anti-microbial antibodies in celiac disease: Trick or treat?

World Journal of Gastroenterology

Volumn 15, Issue 31, 2009, Pages 3891-3900

  Papp, Maria ^a   Foldi, Ildiko ^a   Altorjay, Istvan ^a   Palyu, Eszter ^a   Udvardy, Miklos ^a   Tumpek, Judit ^a   Sipka, Sandor ^a   Korponay Szabo, Ilma Rita ^a,b   Nemes, Eva ^a   Veres, Gabor ^c   Dinya, Tamas ^a   Tordai, Attila ^d   Andrikovics, Hajnalka ^d   Norman, Gary L ^e   Lakatos, Peter Laszlo ^c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d Hungarian National Blood Transfusion Service   (Hungary)

^e INOVA DIAGNOSTICS INC   (United States)

Author keywords

Anti outer membrane protein antibody; Anti Saccharomyces cerevisiae antibodies; Bacterial translocation; Celiac disease; Crohn's disease; Gluten free diet; Glycans; NOD2 CARD15; Presenting symptoms

Indexed keywords

ANTIBODY; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; CASPASE RECRUITMENT DOMAIN PROTEIN 15; FUNGUS ANTIBODY; OUTER MEMBRANE PROTEIN; POLYSACCHARIDE;

ADULT; ARTICLE; BLOOD; CELIAC DISEASE; FEMALE; GENETICS; GLUTEN FREE DIET; HUMAN; HUNGARY; IMMUNOLOGY; MALE; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY;

ADULT; ANTI-INFECTIVE AGENTS; ANTIBODIES; ANTIBODIES, BACTERIAL; ANTIBODIES, FUNGAL; BACTERIAL OUTER MEMBRANE PROTEINS; CELIAC DISEASE; DIET, GLUTEN-FREE; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; HUNGARY; MALE; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; POLYSACCHARIDES;

EID: 70350521184     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.3891     Document Type: Article

References (50)

1. Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology 2005; 128: S47-S51 (Pubitemid 40460821)
2. van Heel DA, West J. Recent advances in coeliac disease. Gut 2006; 55: 1037-1046
3. Shaoul R, Lerner A. Associated autoantibodies in celiac disease. Autoimmun Rev 2007; 6: 559-565
4. Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J, Mack D, Patel D, Moher D. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005; 128: S38-S46 (Pubitemid 40460820)
5. Basso D, Guariso G, Fogar P, Meneghel A, Zambon CF, Navaglia F, Greco E, Schiavon S, Rugge M, Plebani M. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem 2009; 55: 150-157
6. Alaedini A, Green PH. Autoantibodies in celiac disease. Autoimmunity 2008; 41: 19-26
7. Clemente MG, Musu MP, Frau F, Brusco G, Sole G, Corazza GR, De Virgiliis S. Immune reaction against the cytoskeleton in coeliac disease. Gut 2000; 47: 520-526
8. Carroccio A, Brusca I, Iacono G, Alessio MG, Sonzogni A, Di Prima L, Barrale M, Ottomano C, Ambrosiano G, Teresi S, D'Angelo A, Pirrone G, Cefalù B, Scalici C, La Chiusa SM. IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study. Dig Liver Dis 2007; 39: 818-823 (Pubitemid 47215584)
9. Carroccio A, Brusca I, Iacono G, Di Prima L, Teresi S, Pirrone G, Florena AM, La Chiusa SM, Averna MR. Antiactin antibodies in celiac disease: correlation with intestinal mucosa damage and comparison of ELISA with the immunofluorescence assay. Clin Chem 2005; 51: 917-920 (Pubitemid 40577937)
10. Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000; 355: 1518-1519 (Pubitemid 30237361)
11. Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J Gastroenterol 2007; 13: 2028-2036 (Pubitemid 46795837)
12. Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papadakis KA, Taylor KD, Landers CJ, Abreu-Martin MT, Rotter JI, Yang H, Targan SR. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004; 126: 414-424 (Pubitemid 38182298)
13. Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, Foldi I, Lakos G, Tumpek J, Udvardy ML, Harsfalvi J, Fischer S, Lakatos L, Kovacs A, Bene L, Molnar T, Tulassay Z, Miheller P, Veres G, Papp J, Lakatos PL. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis 2007; 13: 984-992
14. Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 2006; 131: 366-378 (Pubitemid 44142445)
15. Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J, Lakatos PL. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol 2008; 103: 665-681
16. Harrer M, Reinisch W, Dejaco C, Kratzer V, Gmeiner M, Miehsler W, Norman GL, Gangl A, Vogelsang H. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur J Gastroenterol Hepatol 2003; 15: 1281-1285 (Pubitemid 39049670)
17. Vermeire S, Peeters M, Vlietinck R, Joossens S, Den Hond E, Bulteel V, Bossuyt X, Geypens B, Rutgeerts P. Anti- Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 2001; 7: 8-15
18. Benjamin J, Makharia GK, Joshi YK. Association between intestinal permeability and anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease. Inflamm Bowel Dis 2008; 14: 1610-1611
19. Vermeire S, Vermeulen N, Van Assche G, Bossuyt X, Rutgeerts P. (Auto)antibodies in inflammatory bowel diseases. Gastroenterol Clin North Am 2008; 37: 429-438, vii
20. Henckaerts L, Pierik M, Joossens M, Ferrante M, Rutgeerts P, Vermeire S. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut 2007; 56: 1536-1542 (Pubitemid 350033192)
21. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434 (Pubitemid 47123518)
22. Toumi D, Mankaï A, Belhadj R, Ghedira-Besbes L, Jeddi M, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in coeliac disease. Scand J Gastroenterol 2007; 42: 821-826 (Pubitemid 46897632)
23. Granito A, Muratori L, Muratori P, Guidi M, Lenzi M, Bianchi FB, Volta U. Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. Gut 2006; 55: 296 (Pubitemid 43117295)
24. Mallant-Hent RCh, Mary B, von Blomberg E, Yüksel Z, Wahab PJ, Gundy C, Meyer GA, Mulder CJ. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Eur J Gastroenterol Hepatol 2006; 18: 75-78 (Pubitemid 43004885)
25. Damoiseaux JG, Bouten B, Linders AM, Austen J, Roozendaal C, Russel MG, Forget PP, Tervaert JW. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol 2002; 22: 281-288 (Pubitemid 35178823)
26. Candelli M, Nista EC, Carloni E, Pignataro G, Rigante D, Gasbarrini A. Anti-Saccharomyces cerevisiae antibodies and coeliac disease. Scand J Gastroenterol 2003; 38: 1191-1192 (Pubitemid 37518606)
27. Ashorn S, Raukola H, Välineva T, Ashorn M, Wei B, Braun J, Rantala I, Kaukinen K, Luukkaala T, Collin P, Mäki M, Iltanen S. Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease. J Clin Immunol 2008; 28: 486-494
28. Ashorn S, Välineva T, Kaukinen K, Ashorn M, Braun J, Raukola H, Rantala I, Collin P, Mäki M, Luukkaala T, Iltanen S. Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J Clin Immunol 2009; 29: 190-195
29. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992; 102: 330-354
30. Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 776-778 (Pubitemid 24193220)
31. Ambrus A, Bányai I, Weiss MS, Hilgenfeld R, Keresztessy Z, Muszbek L, Fésüs L. Calcium binding of transglutaminases: a 43Ca NMR study combined with surface polarity analysis. J Biomol Struct Dyn 2001; 19: 59-74 (Pubitemid 32844638)
32. Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay- Szabó IR, Sarnesto A, Savilahti E, Collin P, Mäki M. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322-1328 (Pubitemid 28545980)
33. Barta Z, Csípõ I, Szabó GG, Szegedi G. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. World J Gastroenterol 2003; 9: 2308-2312 (Pubitemid 37321465)
34. Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, Norman GL, Altstock RT, Van Steen K, Rutgeerts P, Van Assche G, Vermeire S. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007; 56: 1394-1403 (Pubitemid 47517833)
35. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 2006; 55: 1512-1520
36. Meddings J. The significance of the gut barrier in disease. Gut 2008; 57: 438-440
37. Hill PG, Holmes GK. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008; 27: 572-577
38. Santin I, Castellanos-Rubio A, Hualde I, Castaño L, Vitoria JC, Bilbao JR. Toll-like receptor 4 (TLR4) gene polymorphisms in celiac disease. Tissue Antigens 2007; 70: 495-498 (Pubitemid 350075796)
39. Dezsofi A, Szebeni B, Hermann CS, Kapitány A, Veres G, Sipka S, Körner A, Madácsy L, Korponay-Szabó I, Rajczy K, Arató A. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both. J Pediatr Gastroenterol Nutr 2008; 47: 283-287
40. Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, Kuechler I, Krueger S, Schmidt HH, Lochs H. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut 2006; 55: 342-347 (Pubitemid 43268271)
41. Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 2003; 98: 839-843 (Pubitemid 36576311)
42. Rubio-Tapia A, Barton SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol 2009; 43: 157-161
43. Castiglione F, Rispo A, Di Girolamo E, Cozzolino A, Manguso F, Grassia R, Mazzacca G. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther 2003; 18: 1107-1112 (Pubitemid 38021596)
44. Deban L, Correale C, Vetrano S, Malesci A, Danese S. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol 2008; 172: 1457-1466 (Pubitemid 351793339)
45. Myrsky E, Syrjänen M, Korponay-Szabo IR, Mäki M, Kaukinen K, Lindfors K. Altered small-bowel mucosal vascular network in untreated coeliac disease. Scand J Gastroenterol 2009; 44: 162-167
46. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci 2007; 52: 2015-2021 (Pubitemid 47246507)
47. Bethune MT, Khosla C. Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog 2008; 4: e34
48. Koning F. Celiac disease: sandwiched between innate and adaptive immune responses induced by gluten. J Pediatr Gastroenterol Nutr 2008; 46 Suppl 1: E8-E9
49. Desir B, Amre DK, Lu SE, Ohman-Strickland P, Dubinsky M, Fisher R, Seidman EG. Utility of serum antibodies in determining clinical course in pediatric Crohn's disease. Clin Gastroenterol Hepatol 2004; 2: 139-146 (Pubitemid 38180468)
50. Balzan S, de Almeida Quadros C, de Cleva R, Zilberstein B, Cecconello I. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol 2007; 22: 464-471 (Pubitemid 46435001)